Annexin 1: More than an anti-phospholipase protein

Inflammation Research

Volumn 53, Issue 4, 2004, Pages 125-132

  Parente, Luca ^a   Solito, Egle ^a,b  

^a UNIVERSITY OF SALERNO   (Italy)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Annexin 1; Apoptosis; Cell migration; Glucocorticoids; Inflammation

Indexed keywords

CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; L SELECTIN; LIPOCORTIN 1; PHOSPHOLIPASE A2 INHIBITOR; VERY LATE ACTIVATION ANTIGEN 4;

APOPTOSIS; CELL MEMBRANE; CELL MIGRATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; INFLAMMATION; LEUKOCYTE MIGRATION; MICROGLIA; NONHUMAN; PHAGOCYTE; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANNEXIN A1; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CELL MOVEMENT; CYTOSOL; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-10; LEUKOCYTES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHOLIPASES A; VASCULAR CELL ADHESION MOLECULE-1;

EID: 1942486365     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-003-1235-z     Document Type: Review

References (89)

1. Flower RJ. Lipocortin and the mechanism of action of the glucocorticoids. Br J Pharmacol 1988; 94: 987-1015.
2. Flower RJ, Rothwell NJ. Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 1994; 15: 71-6.
3. Crumpton MJ, Dedman JR. Protein terminology tangle. Nature 1990; 345: 212.
4. Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium-and phospholipid-binding proteins. Biochem Biophys Acta 1994; 1197: 63-93.
5. Bomalaski JS, Lawton P, Browning JL. Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints. J Immunol 1991; 146: 3904-10.
6. 2 by 'lipocortins' and calpactins. An effect of binding to substrate phospholipids. J Biol Chem 1987; 262: 1698-1705.
7. 2. Eur J Pharmacol 1997; 326: 237-50.
8. 2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J Clin Invest 1996; 97: 2233-41.
9. 2 by specific interaction, not by substrate depletion. FEBS Lett 1994; 343: 251-5.
10. 2 by annexin I. Specific interaction model and mapping of the interaction site. J Biol Chem 2001; 276: 15712-19.
11. Kim S-W, Ko J, Kim JH, Choi EC, Na DS. Differential effects of annexins I, II, III and V on cytosolic phospholipase A2 activity: specific interaction model. FEBS Lett 2001; 489: 243-8.
12. 2 activity. Br J Pharmacol 1998; 124: 1675-83.
13. -/- mouse. FASEB J 2003; 17: 253-5.
14. 2 signal. FEBS Lett 2000; 477: 244-8.
15. 2 phosphorylation. Biochem Pharmacol 1996; 52: 351-6.
16. Croxtall JD, Choudhury Q, Flower RJ. Inhibitory effect of peptides derived from the N-terminus of lipocortin 1 on arachidonic acid release and proliferation in the A549 cell line: identification of E-Q-E-Y-V as a crucial component. Br J Pharmacol 1998; 123: 975-83.
17. Perretti M. The annexin 1 receptor(s): is the plot unravelling? Trends Pharmacol Sci 2003; 24: 574-9.
18. Wu CC, Croxtall JD, Perretti M, Bryant CE, Thiemermann C, Flower RJ, et al. Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc Natl Acad Sci U S A 1995; 92: 3473-7.
19. Minghetti L, Nicolini A, Polazzi E, Greco A, Perretti M, Parente L, et al. Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1. Br J Pharmacol 1999; 126: 1307-14.
20. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. Activated microglia mediate neuronal cell death injury via a nitric oxide mechanism. J Immunol 1992; 149: 2736-41.
21. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993; 151: 2132-41.
22. Young KA, Hirst WD, Solito E, Wilkin GP. De novo expression of lipocortin-1 in reactive microglia and astrocytes in kainic acid lesioned rat cerebellum. GLIA 1999; 26: 333-43.
23. Newman SP, Flower RJ, Croxtall JD. Dexamethasone suppression of IL-1-induced cyclooxygenase 2 expression is not mediated by lipocortin 1. Biochem Biophys Res Commun 1994; 202: 931-9.
24. Sampey AV, Hutchinson P, Morand EF. Annexin I and dexamethasone effects on phospholipase and cyclooxygenase activity in human synoviocytes. Med Inflamm 2000; 9: 125-32.
25. Ferlazzo V, D'Agostino P, Milano S, Caruso R, Feo S, Cillari E, et al. Anti-inflammatory effects of annexin-1: stimulation of IL-10 release and inhibition of nitric oxide synthesis. Int Immunopharmacol 2003; 3: 1363-9.
26. Mertz PM, DeWitt DL, Stetler-Stevenson WG, Wahl LM. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J Biol Chem 1994; 269: 21322-9.
27. Cunha FQ, Moncada S, Liew FY. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun 1992; 182: 1155-9.
28. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin-10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993; 178: 1041-8.
29. Yi A-K, Yoon J-G, Yeo S-J, Hong S-C, English BK, Krieg AM. Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response. J Immunol 2002; 168: 4711-20.
30. Alldridge LC, Harris HJ, Plevin R, Hannon R, Bryant CE. The annexin protein lipocortin 1 regulates the MAPK/ERK pathway. J Biol Chem 1999; 274: 37620-8.
31. Getting SJ, Flower RJ, Perretti M. Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1. Br J Pharmacol 1997; 120: 1075-82.
32. Mancuso F, Flower RJ, Perretti M. Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule. Involvement of endogenous lipocortin 1. J Immunol 1995; 155: 377-86.
33. Lim LHK, Solito E, Russo-Marie F, Flower RJ, Perretti M. Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc Natl Acad Sci U S A 1998; 95: 14535-9.
34. Perretti M, Croxtall JD, Wheller SK, Goulding NJ, Hannon R, Flower RJ. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nature Med 1996; 2: 1259-62.
35. Oliani SM, Paul-Clark MJ, Christian HC, Flower RJ, Perretti M. Neutrophils interaction with inflamed postcapillary venule endothelium alters annexin 1 expression. Am J Pathol 2001; 158: 603-15.
36. 1 integrin. J Immunol 2000; 165: 1573-81.
37. Perretti M, Ingegnoli F, Wheller SK, Blades MC, Solito E, Pitzalis C. Annexin 1 modulates monocyte-endothelial cell interaction in vitro and cell migration in vivo in the human SCID mouse transplantation model. J Immunol 2002; 169: 2085-92.
38. Walter A, Riehemann K, Gerke V. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Molecular Cell 2000; 5: 831-40.
39. Strausbaugh HJ, Rosen SD. A potential role for annexin 1 as a physiologic mediator of glucocorticoid-induced L-selectin shedding from myeloid cells. J Immunol 2001; 166: 6294-300.
40. Perretti M, Getting SJ, Solito E, Murphy PM, Gao J-L. Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin-1 and its mimetics. Am J Pathol 2001; 158: 1969-73.
41. Chiang N, Fierro IM, Gronert K, Serhan CN. Activation of lipoxin A4 receptors by aspirin-triggered lipoxins ans select peptides evokes ligand-specific responses in inflammation. J Exp Med 2000; 191: 1197-207.
42. Perretti M, Chiang N, La M, Fierro IM, Marullo S, Getting SJ, et al. Endogenous lipid-and peptide-derived anti-inflammatory pathways generated with glucocorticoids and aspirin treatment activate the lipoxin A4 receptor. Nature Med 2002; 8: 1296-302.
43. Meerschaert J, Furie MB. The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium. J Immunol 1995; 154: 4099-112.
44. Srikrishna G, Toomre DK, Manzi A, Panneerselvam K, Freeze HH, Varki A, Varki NM. A novel anionic modification of N-glycans on mammalian endothelial cells is recognised by activated neutrophils and modulate acute inflammatory response. J Immunol 2001; 166: 624-32.
45. Srikrishna G, Panneerselvam K, Westphal V, Abraham V, Varki A, Freeze HH. Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J Immunol 2001; 166: 4678-88.
46. de Coupade C, Solito E, Levine JD. Dexamethasone enhances interaction of endogenous annexin I with L-selectin and triggers shedding of L-selectin in the monocytic cell line U-937. Br J Pharmacol 2003; 140: 133-45.
47. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281: 1305-8.
48. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-12.
49. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281: 1312-6.
50. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 1322-6.
51. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-6.
52. Orth K, Chinnaiyan AM, Garg M, Frolich JC, Dixit VM. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J Biol Chem 1996; 271: 16443-6.
53. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997; 278: 294-8.
54. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD. Nature 1998; 391: 43-50.
55. Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol 1997; 61: 375-80.
56. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002; 2: 965-75.
57. Migliorati G, Nicoletti I, D'Adamio F, Spreca F, Pagliacci C, Riccardi C. Dexamethasone induces apoptosis in mouse natural killer cells and cytotoxic T lymphocytes. Immunology 1994; 81: 21-6.
58. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996; 156: 4422-8.
59. Schmidt M, Pauels H-G, Lügering A, Domschke W, Kucharzik T. Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1b. J Immunol 1999; 163: 3484-90.
60. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 1995; 154: 4719-25.
61. Distelhorst CW. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 2002; 9: 6-19.
62. Helmberg A, Auphan N, Caelles C, Karin M. Glucocorticoid-induced apoptosis oh human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 1995; 14: 452-60.
63. Ramdas J, Harmon JM. Glucocorticoid-induced apoptosis and regulation of NF-kappaB activity in human leukemic T cells. Endocrinology 1998; 139: 3813-21.
64. 2+ fluxes. Proc Natl Acad Sci USA 1994; 91: 6569-73.
65. Khan AA, Soloski MJ, Sharp AH, Schilling G, Sabatini DM, Li SH, et al. Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor. Science 1996; 273: 503-7.
66. Dallaporta B, Pablo M, Maisse C, Daugas E, Loeffler M, Zamzami N, et al. Proteasome activation as a critical event of thymocyte apoptosis. Cell Death Differ 2000; 7: 368-73.
67. Ivanov VN, Nikolic-Zugic J. Biochemical and kinetic characterization of the glucocorticoid-induced apoptosis of immature CD4+CD8+ thymocytes. Int Immunol 1998; 10: 1807-17.
68. Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 2000; 288: 874-7.
69. Gil-Gomez G, Berns A, Brady HJM. A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J 1998; 17: 7209-18.
70. Alam A, Braun MY, Hartgers F, Lesage S, Cohen L, Hugo P, et al. Specific activation of the cysteine protease CPP32 during the negative selection of T cells in the thymus. J Exp Med 1997; 186: 1503-12.
71. Miyashita T, Nagao K, Krajewski S, Salvesen GS, Reed JC, Inoue T, et al. Investigation of glucocorticoid-induced apoptotic pathway: processing of caspase-6 but not caspase-3. Cell Death Differ 1998; 5: 1034-41.
72. Komoriya A, Packard BZ, Brown MJ, Wu M-L, Henkart PA. Assessment of caspase activities in intact apoptotic thymocytes using cell-permeable fluorogrnic caspase substrates. J Exp Med 2000; 191: 1819-28.
73. McKanna JA. Lipocortin 1 in apoptosis: mammary regression. Anat Record 1995; 242: 1-10.
74. 2-treated rat thymocytes by lipocortin I. Biochem Biophys Res Commun 1996; 220: 643-7.
75. Solito E, de Coupade C, Canaider S, Goulding NJ, Perretti M. Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol 2001; 133: 217-28.
76. Debret R, El Btaouri H, Duca L, Rahman I, Radke S, Haye B, et al. Annexin A1 processing is associated with caspase-dependent apoptosis in BZR cells. FEBS Lett 2003; 546: 195-202.
77. Solito E, Kamal A, Russo-Marie F, Buckingham JC, Marullo S, Perretti M. A novel calcium dependent pro-apoptotic effect of annexin I on human neutrophils. FASEB J 2003; 17: 1544-56.
78. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 1999; 284: 339-43.
79. 2 of activation-induced apoptosis of human CD4+CD8+ T lymphocytes. J Immunol 1995; 154: 1041-7.
80. Genaro AM, Hortelano S, Alvarez A, Martinez C, Boscà L. Splenic B lymphocytes programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 1995; 95: 1884-90.
81. Riccardi C, Cifone MG, Migliorati G. Glucocorticoid hormone-induced modulation of gene expression and regulation of T-cell death: role of GITR and GILZ, two dexamethasone-induced genes. Cell Death Differ 1999; 6: 1182-9.
82. Ward C, Chilvers ER, Lawson MF, Pryde JG, Fujihara S, Farrow SN, et al. NF-kappa B activation Is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem 1999; 274: 4309-18.
83. Ravichandran KS. 'Recruitment signals' from apoptotic cells: invitation to a quiet meal. Cell 2003; 113: 817-20.
84. Schlegel RA, Williamson P. Phosphatidylserine, a death knell. Cell Death Differ 2001; 8: 551-63.
85. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-b, PGE2, and PAF. J Clin Invest 1998; 101: 890-8.
86. Huynh M-LN, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-b1 secretion and the resolution of inflammation. J Clin Invest 2003; 109: 41-50.
87. Byrne A, Reen DJ. Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils. J Immunol 2002; 168: 1968-77.
88. Liu Y, Cousin JM, Hughes J, Van Damme J, Seckl JR, Haslett C, et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol 1999; 162: 3639-46.
89. Arur S, Uche UE, Rezaul K, Fong M, Scranton V, Cowan AE, et al. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell 2003; 4: 587-98.